![TIMI Study Group(@TIMIStudyGroup) 's Twitter Profileg](https://pbs.twimg.com/profile_images/1646526646441381892/--ZXuUHF_200x200.jpg)
TIMI Study Group
@TIMIStudyGroup
Providing the latest news and research from the TIMI Study Group, an ARO affiliated with Brigham and Women’s Hospital and Harvard Medical School.
ID:1854335850
http://www.timi.org 11-09-2013 13:41:01
1,8K Tweets
4,0K Followers
325 Following
![Circulation(@CircAHA) 's Twitter Profile Photo Circulation(@CircAHA) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/748173720586493952/psfkHHGV_200x200.jpg)
#ICYMI : Left Main Revascularization in Diabetes #AHAJournals Prakriti Gaba Brian Bergmark TIMI Study Group
![Heart in Diabetes 🫀(@HeartinDiabetes) 's Twitter Profile Photo Heart in Diabetes 🫀(@HeartinDiabetes) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1602378874720952320/oOrfgzWu_200x200.jpg)
Join us for our session, 'Diabetes and CVD' with our renowned speakers at the 8th Heart in Diabetes!
Earn #CME credits and register now at heartindiabetes.com/registration
Liz Selvin David Berg @JohnHopkinsSPH Duke Clinical Research Institute Brigham and Women's Hospital Harvard Medical School TIMI Study Group American Heart Association #HID24
![Heart in Diabetes 🫀 (@HeartinDiabetes) on Twitter photo 2024-04-24 18:01:52 Join us for our session, 'Diabetes and CVD' with our renowned speakers at the 8th Heart in Diabetes! Earn #CME credits and register now at heartindiabetes.com/registration @LizSelvin @ddbergMD @JohnHopkinsSPH @DCRINews @BrighamWomens @harvardmed @TIMIStudyGroup @American_Heart #HID24 Join us for our session, 'Diabetes and CVD' with our renowned speakers at the 8th Heart in Diabetes! Earn #CME credits and register now at heartindiabetes.com/registration @LizSelvin @ddbergMD @JohnHopkinsSPH @DCRINews @BrighamWomens @harvardmed @TIMIStudyGroup @American_Heart #HID24](https://pbs.twimg.com/media/GL8uGO7WMAA3d5p.jpg)
![TIMI Study Group(@TIMIStudyGroup) 's Twitter Profile Photo TIMI Study Group(@TIMIStudyGroup) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1646526646441381892/--ZXuUHF_200x200.jpg)
Clinical Highlights From the American College of Cardiology’s 2024 Scientific Session, including the Bridge-TIMI 73a trial in JAMA Cardiology Brian Bergmark Nicholas Marston
jamanetwork.com/journals/jama/…
![TIMI Study Group(@TIMIStudyGroup) 's Twitter Profile Photo TIMI Study Group(@TIMIStudyGroup) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1646526646441381892/--ZXuUHF_200x200.jpg)
Bridge-TIMI 73a primary results featured in NEJM Journal Watch Brian Bergmark Nicholas Marston #olezarsen
jwatch.org/na57300/2024/0…
![TIMI Study Group(@TIMIStudyGroup) 's Twitter Profile Photo TIMI Study Group(@TIMIStudyGroup) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1646526646441381892/--ZXuUHF_200x200.jpg)
Coverage in Healio of Bridge-TIMI 73a results @brianbergmark Nicholas Marston #olezarsen
healio.com/news/cardiolog…
![TIMI Study Group(@TIMIStudyGroup) 's Twitter Profile Photo TIMI Study Group(@TIMIStudyGroup) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1646526646441381892/--ZXuUHF_200x200.jpg)
![TIMI Study Group(@TIMIStudyGroup) 's Twitter Profile Photo TIMI Study Group(@TIMIStudyGroup) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1646526646441381892/--ZXuUHF_200x200.jpg)
Coverage in Medscape of Brian Bergmark's #ACC24 LBCT presentation of the Bridge-TIMI 73a results. Robert Giugliano Nicholas Marston
medscape.com/viewarticle/ea…
![TIMI Study Group(@TIMIStudyGroup) 's Twitter Profile Photo TIMI Study Group(@TIMIStudyGroup) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1646526646441381892/--ZXuUHF_200x200.jpg)
In this issue of Circulation-“Summarizing Primary Results in Clinical Trials with a Time-to-event Endpoint.” This is the first of a series of statistical review articles for cardiologists from Andrea Bellavia and Sabina Murphy, to be published quarterly. ahajournals.org/doi/10.1161/CI…
![TIMI Study Group (@TIMIStudyGroup) on Twitter photo 2024-04-10 15:06:11 In this issue of @CircAHA-“Summarizing Primary Results in Clinical Trials with a Time-to-event Endpoint.” This is the first of a series of statistical review articles for cardiologists from @andreabellavia and Sabina Murphy, to be published quarterly. ahajournals.org/doi/10.1161/CI… In this issue of @CircAHA-“Summarizing Primary Results in Clinical Trials with a Time-to-event Endpoint.” This is the first of a series of statistical review articles for cardiologists from @andreabellavia and Sabina Murphy, to be published quarterly. ahajournals.org/doi/10.1161/CI…](https://pbs.twimg.com/media/GKz_ko9XAAA1o-W.jpg)
![Circulation(@CircAHA) 's Twitter Profile Photo Circulation(@CircAHA) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/748173720586493952/psfkHHGV_200x200.jpg)
#CircACC24 #SimPub SGLT2i Trialists Consortium: primary benefit of SGLT2i for MACE driven by reduction in CV death, without clear effect on myocardial infarction or stroke Sid M. Patel TIMI Study Group #AHAJournals ahajournals.org/doi/10.1161/CI…
![Circulation (@CircAHA) on Twitter photo 2024-04-07 14:18:18 #CircACC24 #SimPub SGLT2i Trialists Consortium: primary benefit of SGLT2i for MACE driven by reduction in CV death, without clear effect on myocardial infarction or stroke @SidPatelMD @TIMIStudyGroup #AHAJournals ahajournals.org/doi/10.1161/CI… #CircACC24 #SimPub SGLT2i Trialists Consortium: primary benefit of SGLT2i for MACE driven by reduction in CV death, without clear effect on myocardial infarction or stroke @SidPatelMD @TIMIStudyGroup #AHAJournals ahajournals.org/doi/10.1161/CI…](https://pbs.twimg.com/media/GKkX5g6WQAAug1s.jpg)
![Circ: Heart Failure(@CircHF) 's Twitter Profile Photo Circ: Heart Failure(@CircHF) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/986708111682490368/wovSqD0b_200x200.jpg)
Sim Pub w/ #ACC24 in #CircHF by Sid M. Patel et al: Early Serial Assessment of Aggregate Vasoactive Support and Mortality in Cardiogenic Shock: Insights from the CCCTN Registry
ahajournals.org/doi/10.1161/CI… #AHAJournals AHA Science Nancy Sweitzer MDPhD Sid M. Patel
TIMI Study Group
![Circ: Heart Failure (@CircHF) on Twitter photo 2024-04-08 14:46:35 Sim Pub w/ #ACC24 in #CircHF by @SidPatelMD et al: Early Serial Assessment of Aggregate Vasoactive Support and Mortality in Cardiogenic Shock: Insights from the CCCTN Registry ahajournals.org/doi/10.1161/CI… #AHAJournals @AHAScience @DrNancySweitzer @SidPatelMD @TIMIStudyGroup Sim Pub w/ #ACC24 in #CircHF by @SidPatelMD et al: Early Serial Assessment of Aggregate Vasoactive Support and Mortality in Cardiogenic Shock: Insights from the CCCTN Registry ahajournals.org/doi/10.1161/CI… #AHAJournals @AHAScience @DrNancySweitzer @SidPatelMD @TIMIStudyGroup](https://pbs.twimg.com/media/GKpn9H1XEAAHh2n.jpg)
![TIMI Study Group(@TIMIStudyGroup) 's Twitter Profile Photo TIMI Study Group(@TIMIStudyGroup) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1646526646441381892/--ZXuUHF_200x200.jpg)
Elderly pts with ASCVD derive similar to greater CV benefit compared to younger pts with early initiation of #evolocumab up to 8.6 yrs with no significant safety concerns. These findings may be helpful in guiding future US recommendations. Samer Alsaid Robert Giugliano #ACC24
![TIMI Study Group (@TIMIStudyGroup) on Twitter photo 2024-04-08 17:30:14 Elderly pts with ASCVD derive similar to greater CV benefit compared to younger pts with early initiation of #evolocumab up to 8.6 yrs with no significant safety concerns. These findings may be helpful in guiding future US recommendations. @sameralsaid @rgiugliano #ACC24 Elderly pts with ASCVD derive similar to greater CV benefit compared to younger pts with early initiation of #evolocumab up to 8.6 yrs with no significant safety concerns. These findings may be helpful in guiding future US recommendations. @sameralsaid @rgiugliano #ACC24](https://pbs.twimg.com/media/GKqNaw2WkAAVZJ1.jpg)
![Cardiovascular Business(@CardioBusiness) 's Twitter Profile Photo Cardiovascular Business(@CardioBusiness) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1650552278980472846/KjiqMXop_200x200.jpg)
![European Society of Cardiology(@escardio) 's Twitter Profile Photo European Society of Cardiology(@escardio) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1260937097206087681/PO6BSMCI_200x200.jpg)
![ACC Media Center(@ACCmediacenter) 's Twitter Profile Photo ACC Media Center(@ACCmediacenter) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1575193295977955351/7brWtmfn_200x200.jpg)
![Radcliffe Cardiology(@radcliffeCARDIO) 's Twitter Profile Photo Radcliffe Cardiology(@radcliffeCARDIO) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1543883006720573440/JbyL-FKa_200x200.jpg)
🎙️NEW #ACC24 #LBCT Interview 💫Dr Brian Bergmark joins us to discuss findings from a study into #olezarsen in adults with hypertriglyceridemia and #ASCVD .
📽️Watch here👉 tinyurl.com/dxjpr2ee
📊50mg or 80mg olezarsen monthly significantly reduced triglyceride levels in
![Yumi Kang, MD, PhD(@YumiKangEndo) 's Twitter Profile Photo Yumi Kang, MD, PhD(@YumiKangEndo) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1672394895150190593/-ScS4GDR_200x200.jpg)
Phase 2b trial results of olezarsen, an anti-sense oligonucleotide inhibiting ApoC3, demonstrating its efficacy and safety among patients with moderate hypertriglyceridemia. Stay tuned for the ongoing phase 3 trial on olezarsen! TIMI Study Group Brian Bergmark
![Cardiology Today(@CardiologyToday) 's Twitter Profile Photo Cardiology Today(@CardiologyToday) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1136639263880241157/BPlZmZ06_200x200.png)
Monthly #olezarsen reduced #triglyceride levels vs. placebo among patients with predominantly moderate hypertriglyceridemia and elevated CV risk Brian Bergmark Dan Soffer American College of Cardiology #Cardiotwitter #ACC24 Endocrine Today Healio
Read more👇
healio.com/news/cardiolog…
![Cardiology Today(@CardiologyToday) 's Twitter Profile Photo Cardiology Today(@CardiologyToday) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1136639263880241157/BPlZmZ06_200x200.png)
“The triglyceride effect was greater than is possible with currently available treatments,” Brian Bergmark Dan Soffer American College of Cardiology #Cardiotwitter #ACC24 Endocrine Today Healio
Read more👇
healio.com/news/cardiolog…
![ACC Media Center(@ACCmediacenter) 's Twitter Profile Photo ACC Media Center(@ACCmediacenter) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1575193295977955351/7brWtmfn_200x200.jpg)
![Cardiology Today(@CardiologyToday) 's Twitter Profile Photo Cardiology Today(@CardiologyToday) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1136639263880241157/BPlZmZ06_200x200.png)
“The triglyceride effect was greater than is possible with currently available treatments,” Brian Bergmark Dan Soffer American College of Cardiology #Cardiotwitter #ACC24 Endocrine Today Healio
Read more👇
healio.com/news/cardiolog…